Pinyo Pharmacy Ltd., Part. Pharmaceutical Import Profile — Thailand (DGFT 2022–2026)

Name: Pinyo Pharmacy Ltd., Part. Pharmaceutical Import Records from India — 4 Products, $1.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Pinyo Pharmacy Ltd., Part. — Pharmaceutical Importer Profile (2026) | 4 Products, $1.1M Trade | TransData Nexus

Pinyo Pharmacy Ltd., Part.

Pharmaceutical Importer · Thailand · Immunosuppressants Focus · $1.1M Total Trade · DGFT Verified

Pinyo Pharmacy Ltd., Part. is a pharmaceutical importer based in Thailand with a total trade value of $1.1M across 4 products in 4 therapeutic categories. Based on 30 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Pinyo Pharmacy Ltd., Part. sources from 5 verified Indian suppliers, with Troikaa Pharmaceuticals Limited accounting for 53.6% of imports.

Pinyo Pharmacy Ltd., Part. — Import Portfolio & Supplier Network

Pinyo Pharmacy Ltd., Part. import network — 4 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Pinyo Pharmacy Ltd., Part.?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Troikaa Pharmaceuticals Limited	$1.1M	40	53.6%
Naprod Life Sciences Private Limited	$639.4K	51	31.0%
Harson Laboratories	$271.9K

What Formulations Does Pinyo Pharmacy Ltd., Part. Import?

Formulation	Value	Ships
Omeprazole for injection 40MG	$296.1K	35
Suxamethonium chloride injection b.p.	$256.3K	22
Pharmaceuticals formulations-	$150.0K	3
Vancomycin hydrochloride for injection USP 500MG	$146.0K	6
Phentroy phenytoin injection BP 50	$101.7K	4
Pharmaceuticals formulations-	$100.0K	2
Eurythmic,sterile amiodarone	$100.0K	2
Alltrex (methotrexate tablets BP 2.5MG)	$100.0K	2
Eurythmic 200 amiodarone tablets BP 10x10tab b/no.e27566 to e27569 m/d.mar-2024e/d.	$58.6K	3
Pharmaceuticals formulations - heparin	$54.1K	2
Pharmaceuticals formulations- heparin	$54.1K	2
Pharmaceuticals formulations- trovir INJ	$50.5K	2
Vasonit, nitroglycerin injection USP 5	$50.5K	2
Azathioprin tablets BP 50MG	$50.1K	2
Carboplatin injection BP 450MG/45ML	$50.0K	1

Pinyo Pharmacy Ltd., Part. imports 36 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 4 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Methotrexate	Immunosuppressants	$436.7K	13	1.3%	18
2	Amiodarone	Cardiovascular	$350.0K	7	0.5%	15
3	Fluorouracil	Oncology	$176.6K	7	1.4%	13
4	Hydrocortisone	Corticosteroids	$150.0K	3	0.2%	13

Pinyo Pharmacy Ltd., Part. imports 4 pharmaceutical products across 4 categories into Thailand totaling $1.1M.

Pinyo Pharmacy Ltd., Part. — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Pinyo Pharmacy Ltd., Part. is a pharmaceutical importer based in Bangkok, Thailand, specializing in the procurement of finished pharmaceutical formulations. The company operates from its headquarters at 238 Charoen Rat Road, Khlong Ton Sai, Khlong San, Bangkok 10600, Thailand. While specific information about its parent company is not publicly available, Pinyo Pharmacy Ltd., Part. plays a significant role in Thailand's pharmaceutical distribution network by sourcing a diverse range of medications from international suppliers, particularly from India.

The company's import portfolio includes a variety of pharmaceutical products across multiple therapeutic categories, indicating a broad engagement in the Thai pharmaceutical market. This diverse sourcing strategy suggests that Pinyo Pharmacy Ltd., Part. is a key player in the distribution of imported pharmaceutical products within Thailand.

2Distribution Network

Specific details regarding Pinyo Pharmacy Ltd., Part.'s warehouse locations and logistics capabilities are not publicly disclosed. However, given its substantial import activities, including 30 shipments totaling $1.1 million USD from India, it is likely that the company maintains a network of distribution centers to manage inventory and facilitate the timely delivery of pharmaceutical products across Thailand. The company's geographic coverage appears to be nationwide, serving various regions within Thailand.

3Industry Role

Pinyo Pharmacy Ltd., Part. functions primarily as a pharmaceutical importer and distributor within Thailand's supply chain. By sourcing finished pharmaceutical formulations from international suppliers, particularly from India, the company plays a crucial role in ensuring the availability of a wide range of medications in the Thai market. This positions Pinyo Pharmacy Ltd., Part. as a significant intermediary between foreign manufacturers and the Thai healthcare system, contributing to the diversity and accessibility of pharmaceutical products in the country.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Pinyo Pharmacy Ltd., Part.

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Pinyo Pharmacy Ltd., Part. demonstrates a high degree of supplier concentration, with 53.6% of its total imports sourced from TROIKAA PHARMACEUTICALS LIMITED, 31.0% from NAPROD LIFE SCIENCES PRIVATE LIMITED, and 13.2% from HARSON LABORATORIES. This concentration indicates a strategic choice to establish strong, reliable partnerships with a select group of suppliers, potentially ensuring consistent product quality and favorable terms. However, such dependency also poses risks; any disruptions with these key suppliers could significantly impact Pinyo Pharmacy Ltd., Part.'s ability to meet market demand. The company's reliance on a limited number of suppliers suggests a need for robust contingency planning to mitigate potential supply chain disruptions.

2Supply Chain Resilience

The resilience of Pinyo Pharmacy Ltd., Part.'s supply chain is closely tied to the stability and reliability of its primary suppliers. With a significant portion of imports concentrated among a few suppliers, the company may face challenges if any of these suppliers encounter operational issues or regulatory hurdles. The diversity of formulations imported—36 unique formulations—indicates some level of diversification in product offerings, which can help mitigate risks associated with single-product dependencies. However, the company's exposure to specific shipping routes and reliance on suppliers from India necessitate careful monitoring of geopolitical and logistical factors that could affect supply chain continuity.

Importing Pharmaceuticals into Thailand — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Thailand

1Regulatory Authority & Framework

In Thailand, the Food and Drug Administration (FDA) under the Ministry of Public Health is the primary regulatory authority overseeing the importation and distribution of pharmaceutical products. The Thai FDA is responsible for ensuring the safety, efficacy, and quality of drugs entering the Thai market. Key legislation governing pharmaceutical imports includes the Drugs Act B.E. 2510 (1967) and its amendments, which outline the procedures for drug registration, importation, and distribution. The Thai FDA's regulations are designed to protect public health by controlling the quality and safety of pharmaceutical products available in Thailand.

2Import Licensing & GMP

Importers of pharmaceutical products into Thailand must obtain a license from the Thai FDA. This process involves submitting an application that includes detailed product information and compliance with Good Manufacturing Practice (GMP) standards. The Thai FDA recognizes GMP certifications from various international bodies, including the World Health Organization (WHO) and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Importers must ensure that their suppliers hold valid GMP certificates from recognized authorities to facilitate the importation process. Additionally, importers must obtain a License per Invoice (LPI) for each import, which requires the use of the national ID number to access the Thai FDA's system. (en.fda.moph.go.th)

Pinyo Pharmacy Ltd., Part. — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Pinyo Pharmacy Ltd., Part.'s focus on importing immunosuppressants, cardiovascular drugs, and oncology medications aligns with the therapeutic needs of the Thai population. The significant import values in these categories—$437K for methotrexate, $350K for amiodarone, and $177K for fluorouracil—indicate a strong market demand for these treatments. This strategic focus suggests that Pinyo Pharmacy Ltd., Part. is positioning itself to meet critical healthcare needs in Thailand, particularly in areas requiring specialized pharmaceutical interventions.

2Sourcing Profile

Pinyo Pharmacy Ltd., Part. primarily sources generic drugs from India, focusing on finished pharmaceutical formulations. The company's import strategy emphasizes a diverse range of formulations, with 36 unique products imported, indicating a preference for a broad product portfolio. India's established pharmaceutical manufacturing capabilities and competitive pricing make it a strategic sourcing partner for Pinyo Pharmacy Ltd., Part.

3Market Positioning

Based on its product mix, Pinyo Pharmacy Ltd., Part. serves multiple segments of the Thai pharmaceutical market, including retail pharmacies, hospitals, and government tenders. The company's importation of specialized medications such as immunosuppressants, cardiovascular drugs, and oncology treatments suggests a focus on supplying hospitals and specialized clinics. Additionally, the volume and diversity of imports indicate involvement in wholesale distribution, catering to a wide range of healthcare providers across Thailand.

Seller's Guide — How to Become a Supplier to Pinyo Pharmacy Ltd., Part.

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to partner with Pinyo Pharmacy Ltd., Part., especially those offering high-quality generic formulations that meet Thai FDA standards. The company's existing supplier base indicates a preference for established manufacturers with reliable supply chains. New suppliers should demonstrate compliance with international GMP standards and the ability to meet the specific therapeutic needs identified in Pinyo Pharmacy Ltd., Part.'s import portfolio.

2Requirements & Qualifications

Indian exporters seeking to supply Pinyo Pharmacy Ltd., Part. must ensure that their products are registered with the Thai FDA and comply with Thai regulations, including labeling requirements in the Thai language. Products must meet Thai FDA standards for safety, efficacy, and quality, and suppliers must hold valid GMP certifications recognized by the Thai FDA. Additionally, exporters should be prepared to provide all necessary documentation and samples required for the importation process.

3How to Approach

Frequently Asked Questions — Pinyo Pharmacy Ltd., Part.

What products does Pinyo Pharmacy Ltd., Part. import from India?

Pinyo Pharmacy Ltd., Part. imports 4 pharmaceutical products across 4 categories. Top imports: Methotrexate ($436.7K), Amiodarone ($350.0K), Fluorouracil ($176.6K), Hydrocortisone ($150.0K).

Who supplies pharmaceuticals to Pinyo Pharmacy Ltd., Part. from India?

Pinyo Pharmacy Ltd., Part. sources from 5 verified Indian suppliers. The primary supplier is Troikaa Pharmaceuticals Limited (53.6% of imports, $1.1M).

What is Pinyo Pharmacy Ltd., Part.'s total pharmaceutical import value?

Pinyo Pharmacy Ltd., Part.'s total pharmaceutical import value from India is $1.1M, based on 30 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Pinyo Pharmacy Ltd., Part. focus on?

Pinyo Pharmacy Ltd., Part. imports across 4 categories. The largest: Immunosuppressants (39.2%), Cardiovascular (31.4%), Oncology (15.9%).

Get Full Pinyo Pharmacy Ltd., Part. Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 3 company name variants from customs records. For current shipment-level data, contact TransData Nexus.